Specialty Generics Market Size, Share & Trends Analysis By Type (Injectables, Oral Drugs), By Application (Oncology, Inflammatory Conditions, Hepatitis C), By End-use (Specialty, Retail), By Region, and Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1 Specialty Generics Market: Methodology and Scope
                  1.1 Market Segmentation
                      1.1.1 Estimates and Forecast Timeline
                  1.2 Research Methodology
                  1.3 Information Procurement
                      1.3.1 Purchased Database
                      1.3.2 GVR’s Internal Database
                      1.3.3 Secondary Sources
                      1.3.4 Primary Research
                      1.3.5 Details of Primary Research
                  1.4 Information or Data Analysis
                      1.4.1 Data Analysis Models
                  1.5 Market Formulation & Validation
                  1.6 Model Details
                      1.6.1 Commodity Flow Analysis
                          1.6.1.1 Approach 1: Commodity Flow Approach
                          1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
                  1.7 Global Market: CAGR Calculation
                  1.8 Research Assumptions
                  1.9 List of Secondary Sources
                  1.10 List of Primary Sources
                  1.11 List of Abbreviations
                  1.12 Objectives
                      1.12.1 Objective 1
                      1.12.2 Objective 2
                      1.12.3 Objective 3
                      1.12.4 Objective 4
Chapter 2 Specialty Generics Market: Executive Summary
                  2.1 Market Snapshot
Chapter 3 Specialty Generics Market: Variables, Trends, & Scope
                  3.1 Market Lineage Outlook
                      3.1.1 Parent Market Outlook
                  3.2 Penetration & Growth Prospect Mapping
                  3.3 Regulatory and Reimbursement Framework
                  3.4 Market Variable Analysis
                      3.4.1 Market driver analysis
                          3.4.1.1 Rising number of off-patent specialty drugs
                          3.4.1.2 Escalating demand for low-cost generic specialty drugs
                          3.4.1.3 Increasing prevalence of chronic disease
                          3.4.1.4 Increasing emphasis to cut down healthcare expenditure
                      3.4.2 Market restraint analysis
                          3.4.2.1 High costs associated with specialty generics
                          3.4.2.2 Delay in new drug launches
                  3.5 Industry Analysis Tools
                      3.5.1 Porter's five forces analysis
                      3.5.2 PESTEL Analysis
                  3.6 Pipeline Analysis
Chapter 4 Specialty Generics Market - Segment Analysis, by Type, 2018 - 2030 (USD Billion)
                  4.1 Specialty Generics Market: Type Movement Analysis
                  4.2 Injectables
                      4.2.1 Injectables market, 2018 - 2030 (USD Billion)
                  4.3 Oral Drugs
                      4.3.1 Oral drugs market, 2018 - 2030 (USD Billion)
                  4.4 Others
                      4.4.1 Others market, 2018 - 2030 (USD Billion)
Chapter 5 Specialty generics Market - Segment Analysis, by Application, 2018 - 2030 (USD Billion)
                  5.1 Specialty Generics Market: Application Movement Analysis
                  5.2 Oncology
                      5.2.1 Oncology market, 2018 - 2030 (USD Billion)
                  5.3 Inflammatory Conditions
                      5.3.1 Inflammatory conditions market, 2018 - 2030 (USD Billion)
                  5.4 Multiple Sclerosis
                      5.4.1 Multiple sclerosis market, 2018 - 2030 (USD Billion)
                  5.5 Hepatitis C
                      5.5.1 Hepatitis C market, 2018 - 2030 (USD Billion)
                  5.6 Others
                      5.6.1 Others market, 2018 - 2030 (USD Billion)
Chapter 6 Specialty generics Market - Segment Analysis, by End-Use, 2018 - 2030 (USD Billion)
                  6.1 Specialty Generics Market: End-Use Movement Analysis
                  6.2 Specialty Pharmacy
                      6.2.1 Specialty pharmacy market, 2018 - 2030 (USD Billion)
                  6.3 Retail Pharmacy
                      6.3.1 Retail pharmacy market, 2018 - 2030 (USD Billion)
                  6.4 Hospital Pharmacy
                      6.4.1 Hospital pharmacy market, 2018 - 2030 (USD Billion)
Chapter 7 Specialty Generics Market - Regional Analysis, 2018 - 2030 (USD Billion)
                  7.1 Market Size, & Forecasts, Revenue and Trend Analysis, 2022 to 2030
                      7.1.1 North America
                          7.1.1.1 North America specialty generics market estimates and forecast, 2018 - 2030 (USD Million)
                          7.1.1.2 U.S.
                              7.1.1.2.1 Key Country Dynamics
                              7.1.1.2.2 Competitive Scenario
                              7.1.1.2.3 Regulatory Framework
                              7.1.1.2.4 Reimbursement Scenario
                              7.1.1.2.5 U.S. specialty generics market estimates and forecast, 2018 - 2030 (USD Million)
                          7.1.1.3 Canada
                              7.1.1.3.1 Key Country Dynamics
                              7.1.1.3.2 Competitive Scenario
                              7.1.1.3.3 Regulatory Framework
                              7.1.1.3.4 Reimbursement Scenario
                              7.1.1.3.5 Canada specialty generics market estimates and forecast, 2018 - 2030 (USD Million)
                      7.1.2 Europe
                          7.1.2.1 Europe specialty generics market estimates and forecast, 2018 - 2030 (USD Million)
                          7.1.2.2 UK
                              7.1.2.2.1 Key Country Dynamics
                              7.1.2.2.2 Competitive Scenario
                              7.1.2.2.3 Regulatory Framework
                              7.1.2.2.4 Reimbursement Scenario
                              7.1.2.2.5 UK specialty generics market estimates and forecast, 2018 - 2030 (USD Million)
                          7.1.2.3 Germany
                              7.1.2.3.1 Key Country Dynamics
                              7.1.2.3.2 Competitive Scenario
                              7.1.2.3.3 Regulatory Framework
                              7.1.2.3.4 Reimbursement Scenario
                              7.1.2.3.5 Germany specialty generics market estimates and forecast, 2018 - 2030 (USD Million)
                          7.1.2.4 Spain
                              7.1.2.4.1 Key Country Dynamics
                              7.1.2.4.2 Competitive Scenario
                              7.1.2.4.3 Regulatory Framework
                              7.1.2.4.4 Reimbursement Scenario
                              7.1.2.4.5 Spain specialty generics market estimates and forecast, 2018 - 2030 (USD Million)
                          7.1.2.5 France
                              7.1.2.5.1 Key Country Dynamics
                              7.1.2.5.2 Competitive Scenario
                              7.1.2.5.3 Regulatory Framework
                              7.1.2.5.4 Reimbursement Scenario
                              7.1.2.5.5 France specialty generics market estimates and forecast, 2018 - 2030 (USD Million)
                          7.1.2.6 Italy
                              7.1.2.6.1 Key Country Dynamics
                              7.1.2.6.2 Competitive Scenario
                              7.1.2.6.3 Regulatory Framework
                              7.1.2.6.4 Reimbursement Scenario
                              7.1.2.6.5 Italy specialty generics market estimates and forecast, 2018 - 2030 (USD Million)
                          7.1.2.7 Denmark
                              7.1.2.7.1 Key Country Dynamics
                              7.1.2.7.2 Competitive Scenario
                              7.1.2.7.3 Regulatory Framework
                              7.1.2.7.4 Reimbursement Scenario
                              7.1.2.7.5 Denmark specialty generics market estimates and forecast, 2018 - 2030 (USD Million)
                          7.1.2.8 Sweden
                              7.1.2.8.1 Key Country Dynamics
                              7.1.2.8.2 Competitive Scenario
                              7.1.2.8.3 Regulatory Framework
                              7.1.2.8.4 Reimbursement Scenario
                              7.1.2.8.5 Sweden specialty generics market estimates and forecast, 2018 - 2030 (USD Million)
                          7.1.2.9 Norway
                              7.1.2.9.1 Key Country Dynamics
                              7.1.2.9.2 Competitive Scenario
                              7.1.2.9.3 Regulatory Framework
                              7.1.2.9.4 Reimbursement Scenario
                              7.1.2.9.5 Norway specialty generics market estimates and forecast, 2018 - 2030 (USD Million)
                      7.1.3 Asia Pacific
                          7.1.3.1 Asia Pacific specialty generics market estimates and forecast, 2018 - 2030 (USD Million)
                          7.1.3.2 Japan
                              7.1.3.2.1 Key Country Dynamics
                              7.1.3.2.2 Competitive Scenario
                              7.1.3.2.3 Regulatory Framework
                              7.1.3.2.4 Reimbursement Scenario
                              7.1.3.2.5 Japan specialty generics market estimates and forecast, 2018 - 2030 (USD Million)
                          7.1.3.3 China
                              7.1.3.3.1 Key Country Dynamics
                              7.1.3.3.2 Competitive Scenario
                              7.1.3.3.3 Regulatory Framework
                              7.1.3.3.4 Reimbursement Scenario
                              7.1.3.3.5 China specialty generics market estimates and forecast, 2018 - 2030 (USD Million)
                          7.1.3.4 India
                              7.1.3.4.1 Key Country Dynamics
                              7.1.3.4.2 Competitive Scenario
                              7.1.3.4.3 Regulatory Framework
                              7.1.3.4.4 Reimbursement Scenario
                              7.1.3.4.5 India specialty generics market estimates and forecast, 2018 - 2030 (USD Million)
                          7.1.3.5 South Korea
                              7.1.3.5.1 Key Country Dynamics
                              7.1.3.5.2 Competitive Scenario
                              7.1.3.5.3 Regulatory Framework
                              7.1.3.5.4 Reimbursement Scenario
                              7.1.3.5.5 South Korea specialty generics market estimates and forecast, 2018 - 2030 (USD Million)
                          7.1.3.6 Australia
                              7.1.3.6.1 Key Country Dynamics
                              7.1.3.6.2 Competitive Scenario
                              7.1.3.6.3 Regulatory Framework
                              7.1.3.6.4 Reimbursement Scenario
                              7.1.3.6.5 Australia specialty generics market estimates and forecast, 2018 - 2030 (USD Million)
                          7.1.3.7 Thailand
                              7.1.3.8.1 Key Country Dynamics
                              7.1.3.8.2 Competitive Scenario
                              7.1.3.8.3 Regulatory Framework
                              7.1.3.8.4 Reimbursement Scenario
                              7.1.3.8.5 Thailand specialty generics market estimates and forecast, 2018 - 2030 (USD Million)
                      7.1.4 Latin America
                          7.1.4.1 Latin America specialty generics market estimates and forecast, 2018 - 2030 (USD Million)
                          7.1.4.2 Brazil
                              7.1.4.2.1 Key Country Dynamics
                              7.1.4.2.2 Competitive Scenario
                              7.1.4.2.3 Regulatory Framework
                              7.1.4.2.4 Reimbursement Scenario
                              7.1.4.2.5 Brazil specialty generics market estimates and forecast, 2018 - 2030 (USD Million)
                          7.1.4.3 Mexico
                              7.1.4.3.1 Key Country Dynamics
                              7.1.4.3.2 Competitive Scenario
                              7.1.4.3.3 Regulatory Framework
                              7.1.4.3.4 Reimbursement Scenario
                              7.1.4.3.5 Mexico specialty generics market estimates and forecast, 2018 - 2030 (USD Million)
                          7.1.4.4 Argentina
                              7.1.4.4.1 Key Country Dynamics
                              7.1.4.4.2 Competitive Scenario
                              7.1.4.4.3 Regulatory Framework
                              7.1.4.4.4 Reimbursement Scenario
                              7.1.4.4.5 Argentina specialty generics market estimates and forecast, 2018 - 2030 (USD Million)
                      7.1.5 MEA
                          7.1.5.1 MEA specialty generics market estimates and forecast, 2018 - 2030 (USD Million)
                          7.1.5.2 South Africa
                              7.1.5.2.1 Key Country Dynamics
                              7.1.5.2.2 Competitive Scenario
                              7.1.5.2.3 Regulatory Framework
                              7.1.5.2.4 Reimbursement Scenario
                              7.1.5.2.5 South Africa specialty generics market estimates and forecast, 2018 - 2030 (USD Million)
                          7.1.5.3 Saudi Arabia
                              7.1.5.3.1 Key Country Dynamics
                              7.1.5.3.2 Competitive Scenario
                              7.1.5.3.3 Regulatory Framework
                              7.1.5.3.4 Reimbursement Scenario
                              7.1.5.3.5 Saudi Arabia specialty generics market estimates and forecast, 2018 - 2030 (USD Million)
                          7.1.5.4 UAE
                              7.1.5.4.1 Key Country Dynamics
                              7.1.5.4.2 Competitive Scenario
                              7.1.5.4.3 Regulatory Framework
                              7.1.5.4.4 Reimbursement Scenario
                              7.1.5.4.5 UAE specialty generics market estimates and forecast, 2018 - 2030 (USD Million)
                          7.1.5.5 Kuwait
                              7.1.5.5.1 Key Country Dynamics
                              7.1.5.5.2 Competitive Scenario
                              7.1.5.5.3 Regulatory Framework
                              7.1.5.5.4 Reimbursement Scenario
                              7.1.5.5.5 Kuwait specialty generics market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8 Specialty Generics Market-Competitive Analysis
                  8.1 Major Deals and Strategic Alliances Analysis
                      8.1.1 New Product Launch
                      8.1.2 Mergers and Acquisitions
                      8.1.3 Partnerships and Strategic Collaborations
                      8.1.4 Conferences and Campaigns
                  8.2 Company Categorization
                      8.2.1 Market Differentiators
                      8.2.2 Innovators
                      8.2.3 Market Leaders
                  8.3 Vendor Landscape
                      8.3.1 List of key distributors and channel partners
                      8.3.2 Key customers
                  8.4 Heat map analysis
                  8.5 Public Companies
                      8.5.1 Key company market share analysis, 2021
                      8.5.2 Company Market Position Analysis
                  8.6 Private Companies
                      8.6.1 List of key emerging companies
                      8.6.2 Regional Network Map
                  8.7 Company Profiles
                      8.7.1 Teva Pharmaceutical Industries Ltd
                          8.7.1.1 Company overview
                          8.7.1.2 Financial performance
                          8.7.1.3 Product benchmarking
                          8.7.1.4 Strategic initiatives
                      8.7.2 Viatris Inc.
                          8.7.2.1 Company overview
                          8.7.2.2 Financial performance
                          8.7.2.3 Product benchmarking
                          8.7.2.4 Strategic initiatives
                      8.7.3 Novartis AG (Sandoz International GmbH)
                          8.7.3.1 Company overview
                          8.7.3.2 Financial performance
                          8.7.3.3 Product benchmarking
                          8.7.3.4 Strategic initiatives
                      8.7.4 Fresenius Kabi Brasil Ltda
                          8.7.4.1 Company overview
                          8.7.4.2 Financial performance
                          8.7.4.3 Product benchmarking
                          8.7.4.4 Strategic initiatives
                      8.7.5 Mallinckrodt
                          8.7.5.1 Company overview
                          8.7.5.2 Financial performance
                          8.7.5.3 Product benchmarking
                          8.7.5.4 Strategic initiatives
                      8.7.6 Bausch Health Companies Inc. (Valeant Pharmaceuticals International, Inc.)
                          8.7.6.1 Company overview
                          8.7.6.2 Financial performance
                          8.7.6.3 Product benchmarking
                          8.7.6.4 Strategic initiatives
                      8.7.7 STADA Arzneimittel AG
                          8.7.7.1 Company overview
                          8.7.7.2 Financial performance
                          8.7.7.3 Product benchmarking
                      8.7.8 Endo Pharmaceuticals Inc.
                          8.7.8.1 Company overview
                          8.7.8.2 Financial performance
                          8.7.8.3 Product benchmarking
                          8.7.8.4 Strategic initiatives
                      8.7.9 Apotex Corp.
                          8.7.9.1 Company overview
                          8.7.9.2 Product benchmarking
                          8.7.9.3 Strategic initiatives
                      8.7.10 Sun Pharmaceutical Industries Ltd.
                          8.7.10.1 Company overview
                          8.7.10.2 Financial performance
                          8.7.10.3 Product benchmarking
                          8.7.10.4 Strategic initiatives
                      8.7.11 Dr. Reddy's Laboratories Ltd
                          8.7.11.1 Company overview
                          8.7.11.2 Financial performance
                          8.7.11.3 Product benchmarking
                          8.7.11.4 Strategic initiatives
                      8.7.12 Hikma Pharmaceuticals PLC
                          8.7.12.1 Company overview
                          8.7.12.2 Financial performance
                          8.7.12.3 Product benchmarking
                          8.7.12.4 Strategic initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 Regulatory framework
Table 4 Leading market players anticipated to witness highest growth
Table 5 List of key distributors and compounding pharmacies
Table 6 North America Specialty Generics Market, By Type, 2018 - 2030 (USD Billion)
Table 7 North America Specialty Generics Market, By Application, 2018 - 2030 (USD Billion)
Table 8 North America Specialty Generics Market, By End-Use, 2018 - 2030 (USD Billion)
Table 9 U.S. Specialty Generics Market, By Type, 2018 - 2030 (USD Billion)
Table 10 U.S. Specialty Generics Market, By Application, 2018 - 2030 (USD Billion)
Table 11 U.S. Specialty Generics Market, By End-Use, 2018 - 2030 (USD Billion)
Table 12 Canada Specialty Generics Market, By Type, 2018 - 2030 (USD Billion)
Table 13 Canada Specialty Generics Market, By Application, 2018 - 2030 (USD Billion)
Table 14 Canada Specialty Generics Market, By End-Use, 2018 - 2030 (USD Billion)
Table 15 Europe Specialty Generics Market, By Type, 2018 - 2030 (USD Billion)
Table 16 Europe Specialty Generics Market, By Application, 2018 - 2030 (USD Billion)
Table 17 Europe Specialty Generics Market, By End-Use, 2018 - 2030 (USD Billion)
Table 18 UK Specialty Generics Market, By Type, 2018 - 2030 (USD Billion)
Table 19 UK Specialty Generics Market, By Application, 2018 - 2030 (USD Billion)
Table 20 UK Specialty Generics Market, By End-Use, 2018 - 2030 (USD Billion)
Table 21 Germany Specialty Generics Market, By Type, 2018 - 2030 (USD Billion)
Table 22 Germany Specialty Generics Market, By Application, 2018 - 2030 (USD Billion)
Table 23 Germany Specialty Generics Market, By End-Use, 2018 - 2030 (USD Billion)
Table 24 France Specialty Generics Market, By Type, 2018 - 2030 (USD Billion)
Table 25 France Specialty Generics Market, By Application, 2018 - 2030 (USD Billion)
Table 26 France Specialty Generics Market, By End-Use, 2018 - 2030 (USD Billion)
Table 27 Italy Specialty Generics Market, By Type, 2018 - 2030 (USD Billion)
Table 28 Italy Specialty Generics Market, By Application, 2018 - 2030 (USD Billion)
Table 29 Italy Specialty Generics Market, By End-Use, 2018 - 2030 (USD Billion)
Table 30 Spain Specialty Generics Market, By Type, 2018 - 2030 (USD Billion)
Table 31 Spain Specialty Generics Market, By Application, 2018 - 2030 (USD Billion)
Table 32 Spain Specialty Generics Market, By End-Use, 2018 - 2030 (USD Billion)
Table 33 Denmark Specialty Generics Market, By Type, 2018 - 2030 (USD Billion)
Table 34 Denmark Specialty Generics Market, By Application, 2018 - 2030 (USD Billion)
Table 35 Denmark Specialty Generics Market, By End-Use, 2018 - 2030 (USD Billion)
Table 36 Sweden Specialty Generics Market, By Type, 2018 - 2030 (USD Billion)
Table 37 Sweden Specialty Generics Market, By Application, 2018 - 2030 (USD Billion)
Table 38 Sweden Specialty Generics Market, By End-Use, 2018 - 2030 (USD Billion)
Table 39 Norway Specialty Generics Market, By Type, 2018 - 2030 (USD Billion)
Table 40 Norway Specialty Generics Market, By Application, 2018 - 2030 (USD Billion)
Table 41 Norway Specialty Generics Market, By End-Use, 2018 - 2030 (USD Billion)
Table 42 Asia Pacific Specialty Generics Market, By Type, 2018 - 2030 (USD Billion)
Table 43 Asia Pacific Specialty Generics Market, By Application, 2018 - 2030 (USD Billion)
Table 44 Asia Pacific Specialty Generics Market, By End-Use, 2018 - 2030 (USD Billion)
Table 45 Japan Specialty Generics Market, By Type, 2018 - 2030 (USD Billion)
Table 46 Japan Specialty Generics Market, By Application, 2018 - 2030 (USD Billion)
Table 47 Japan Specialty Generics Market, By End-Use, 2018 - 2030 (USD Billion)
Table 48 China Specialty Generics Market, By Type, 2018 - 2030 (USD Billion)
Table 49 China Specialty Generics Market, By Application, 2018 - 2030 (USD Billion)
Table 50 China Specialty Generics Market, By End-Use, 2018 - 2030 (USD Billion)
Table 51 India Specialty Generics Market, By Type, 2018 - 2030 (USD Billion)
Table 52 India Specialty Generics Market, By Application, 2018 - 2030 (USD Billion)
Table 53 India Specialty Generics Market, By End-Use, 2018 - 2030 (USD Billion)
Table 54 Australia Specialty Generics Market, By Type, 2018 - 2030 (USD Billion)
Table 55 Australia Specialty Generics Market, By Application, 2018 - 2030 (USD Billion)
Table 56 Australia Specialty Generics Market, By End-Use, 2018 - 2030 (USD Billion)
Table 57 South Korea Specialty Generics Market, By Type, 2018 - 2030 (USD Billion)
Table 58 South Korea Specialty Generics Market, By Application, 2018 - 2030 (USD Billion)
Table 59 South Korea Specialty Generics Market, By End-Use, 2018 - 2030 (USD Billion)
Table 60 Thailand Specialty Generics Market, By Type, 2018 - 2030 (USD Billion)
Table 61 Thailand Specialty Generics Market, By Application, 2018 - 2030 (USD Billion)
Table 62 Thailand Specialty Generics Market, By End-Use, 2018 - 2030 (USD Billion)
Table 63 Latin America Specialty Generics Market, By Type, 2018 - 2030 (USD Billion)
Table 64 Latin America Specialty Generics Market, By Application, 2018 - 2030 (USD Billion)
Table 65 Latin America Specialty Generics Market, By End-Use, 2018 - 2030 (USD Billion)
Table 66 Brazil Specialty Generics Market, By Type, 2018 - 2030 (USD Billion)
Table 67 Brazil Specialty Generics Market, By Application, 2018 - 2030 (USD Billion)
Table 68 Brazil Specialty Generics Market, By End-Use, 2018 - 2030 (USD Billion)
Table 69 Mexico Specialty Generics Market, By Type, 2018 - 2030 (USD Billion)
Table 70 Mexico Specialty Generics Market, By Application, 2018 - 2030 (USD Billion)
Table 71 Mexico Specialty Generics Market, By End-Use, 2018 - 2030 (USD Billion)
Table 72 Argentina Specialty Generics Market, By Type, 2018 - 2030 (USD Billion)
Table 73 Argentina Specialty Generics Market, By Application, 2018 - 2030 (USD Billion)
Table 74 Argentina Specialty Generics Market, By End-Use, 2018 - 2030 (USD Billion)
Table 75 Middle East & Africa Specialty Generics Market, By Type, 2018 - 2030 (USD Billion)
Table 76 Middle East & Africa Specialty Generics Market, By Application, 2018 - 2030 (USD Billion)
Table 77 Middle East & Africa Specialty Generics Market, By End-Use, 2018 - 2030 (USD Billion)
Table 78 South Africa Specialty Generics Market, By Type, 2018 - 2030 (USD Billion)
Table 79 South Africa Specialty Generics Market, By Application, 2018 - 2030 (USD Billion)
Table 80 South Africa Specialty Generics Market, By End-Use, 2018 - 2030 (USD Billion)
Table 81 Saudi Arabia Specialty Generics Market, By Type, 2018 - 2030 (USD Billion)
Table 82 Saudi Arabia Specialty Generics Market, By Application, 2018 - 2030 (USD Billion)
Table 83 Saudi Arabia Specialty Generics Market, By End-Use, 2018 - 2030 (USD Billion)
Table 84 UAE Specialty Generics Market, By Type, 2018 - 2030 (USD Billion)
Table 85 UAE Specialty Generics Market, By Application, 2018 - 2030 (USD Billion)
Table 86 UAE Specialty Generics Market, By End-Use, 2018 - 2030 (USD Billion)
Table 87 Kuwait Specialty Generics Market, By Type, 2018 - 2030 (USD Billion)
Table 88 Kuwait Specialty Generics Market, By Application, 2018 - 2030 (USD Billion)
Table 89 Kuwait Specialty Generics Market, By End-Use, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Specialty Generics Market Segmentation
Fig. 2 Market Research Process
Fig. 3 Information Procurement
Fig. 4 Primary Research Pattern
Fig. 5 Market Research Approaches
Fig. 6 Value-Chain-Based Sizing & Forecasting
Fig. 7 QFD Modeling for Market Share Assessment
Fig. 8 Market Formulation & Validation
Fig. 9 Market Summary
Fig. 10 Penetration & Growth Prospect Mapping
Fig. 11 Market Driver Impact Analysis (Current & future impact)
Fig. 12 Market Restraint Impact Analysis (Current & future impact)
Fig. 13 Porter's Five Forces Analysis
Fig. 14 Specialty generics market type outlook: Key takeaways
Fig. 15 Injectables market, 2018 - 2030 (USD Billion)
Fig. 16 Oral drugs market, 2018 - 2030 (USD Billion)
Fig. 17 Others market, 2018 - 2030 (USD Billion)
Fig. 18 Specialty generics market application outlook: Key takeaways
Fig. 19 Specialty generics market: Application movement analysis
Fig. 20 Oncology market, 2018 - 2030 (USD Billion)
Fig. 21 Inflammatory conditions market, 2018 - 2030 (USD Billion)
Fig. 22 Multiple sclerosis market, 2018 - 2030 (USD Billion)
Fig. 23 Hepatitis C market, 2018 - 2030 (USD Billion)
Fig. 24 Others market, 2018 - 2030 (USD Billion)
Fig. 25 Specialty generics market end-use outlook: Key takeaways
Fig. 26 Specialty generics market: End-use movement analysis
Fig. 27 Specialty pharmacy market, 2018 - 2030 (USD Billion)
Fig. 28 Retail pharmacy market, 2018 - 2030 (USD Billion)
Fig. 29 Hospital pharmacy market, 2018 - 2030 (USD Billion)
Fig. 30 Specialty generics: Regional Outlook
Fig. 31 Regional outlook, 2022 & 2030
Fig. 32 North America SWOT Analysis
Fig. 33 North America market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 34 U.S. country dynamics
Fig. 35 U.S. market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 36 Canada country dynamics
Fig. 37 Canada market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 38 Europe SWOT Analysis
Fig. 39 Europe market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 40 UK country dynamics
Fig. 41 UK market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 42 Germany country dynamics
Fig. 43 Germany market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 44 France country dynamics
Fig. 45 France market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 46 Spain country dynamics
Fig. 47 Spain market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 48 Italy country dynamics
Fig. 49 Italy market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 50 Denmark country dynamics
Fig. 51 Denmark market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 52 Sweden country dynamics
Fig. 53 Sweden market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 54 Norway country dynamics
Fig. 55 Norway market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 56 Asia-Pacific SWOT Analysis
Fig. 57 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 58 Japan country dynamics
Fig. 59 Japan market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 60 China country dynamics
Fig. 61 China market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 62 India country dynamics
Fig. 63 India market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 64 Australia country dynamics
Fig. 65 Australia market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 66 South Korea country dynamics
Fig. 67 South Korea market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 68 Thailand country dynamics
Fig. 69 Thailand market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 70 Latin America SWOT Analysis
Fig. 71 Latin America market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 72 Brazil country dynamics
Fig. 73 Brazil market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 74 Mexico country dynamics
Fig. 75 Mexico market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 76 Argentina country dynamics
Fig. 77 Argentina market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 78 Middle East & Africa SWOT Analysis
Fig. 79 MEA market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 80 South Africa country dynamics
Fig. 81 South Africa market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 82 Saudi Arabia country dynamics
Fig. 83 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 84 UAE country dynamics
Fig. 85 UAE market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 86 Kuwait country dynamics
Fig. 87 Kuwait market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 88 Market differentiators
Fig. 89 Heat Map Analysis
Fig. 90 Key company market share analysis, 2022
Fig. 91 Company market position analysis
Fig. 92 Company market position analysis